Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer’s Disease
John W. Wright, Joseph W. Harding
Journal of Alzheimer s Disease (2019) Vol. 67, Iss. 2, pp. 469-480
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Cognitive impact of COVID-19: looking beyond the short term
J. Scott Miners, Patrick G. Kehoe, Seth Love
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 219
ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease
Charles E. Evans, J. Scott Miners, Giulia Piva, et al.
Acta Neuropathologica (2020) Vol. 139, Iss. 3, pp. 485-502
Open Access | Times Cited: 128
Brain Renin–Angiotensin System at the Intersect of Physical and Cognitive Frailty
Çağlar Coşarderelioğlu, Lolita S. Nidadavolu, Claudene J. George, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 108
The Angiotensin AT2Receptor: From a Binding Site to a Novel Therapeutic Target
U. Muscha Steckelings, Robert E. Widdop, Edward D. Sturrock, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 1051-1135
Open Access | Times Cited: 53
Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury
Murat Öz, Dietrich E. Lorke
Biomedicine & Pharmacotherapy (2021) Vol. 136, pp. 111193-111193
Open Access | Times Cited: 52
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
Carmen M. Labandeira, María A. Pedrosa, Aloia Quijano, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 30
Statins and cognition: Modifying factors and possible underlying mechanisms
Tahereh Jamshidnejad-Tosaramandani, Soheila Kashanian, Mohamed H. Al-Sabri, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 30
Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer’s disease: A nationwide population-based cohort study
Hyun Woo Lee, Seung Yeon Kim, Youngkwon Jo, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 22
Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
Louise Reveret, Manon Leclerc, Vincent Émond, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 17
The Discovery of New Inhibitors of Insulin-Regulated Aminopeptidase by a High-Throughput Screening of 400,000 Drug-like Compounds
Johan Gising, Saman Honarnejad, Maaike Bras, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4084-4084
Open Access | Times Cited: 8
How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis
Fabio Panariello, Lorenzo Cellini, Maurizio Speciani, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 43
Angiotensin Receptor Blockers and Cognition: a Scoping Review
Zhen Zhou, Suzanne G. Orchard, Mark Nelson, et al.
Current Hypertension Reports (2023) Vol. 26, Iss. 1, pp. 1-19
Open Access | Times Cited: 15
Role of Inflammation in the Development of COVID-19 to Parkinson’s Disease
Tingting Liu, Haojie Wu, Lin Sun, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3259-3282
Open Access | Times Cited: 5
Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer’s and Parkinson’s Diseases in Young Urbanites Exposed to Air Pollution
Lilian Calderón‐Garcidueñas, Ricardo Torres‐Jardón, Maricela Franco-Lira, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 2, pp. 479-503
Closed Access | Times Cited: 36
Progranulin in neurodegenerative dementia
Xiaoming Wang, Peng Zeng, Ying‐Yan Fang, et al.
Journal of Neurochemistry (2021) Vol. 158, Iss. 2, pp. 119-137
Open Access | Times Cited: 30
The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer’s Disease Pathology
Huan Cui, Si Su, Yan Cao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 30
Microanalysis of Brain Angiotensin Peptides Using Ultrasensitive Capillary Electrophoresis Trapped Ion Mobility Mass Spectrometry
Kellen DeLaney, Dashuang Jia, Laxmi Iyer, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 25, pp. 9018-9025
Open Access | Times Cited: 19
ACE2/ANG-(1-7)/Mas receptor axis activation prevents inflammation and improves cognitive functions in streptozotocin induced rat model of Alzheimer's disease-like phenotypes
Virendra Tiwari, Jitendra Singh, Priya Tiwari, et al.
European Journal of Pharmacology (2023) Vol. 946, pp. 175623-175623
Closed Access | Times Cited: 12
Integration of Phytochemical Profiling and Computational Approaches to Evaluate the Neuroprotective Potential of Nardostachys jatamansi in Alzheimer's Disease
Abdul Jalil Shah, Mohammad Younis Dar, Mohd Adnan, et al.
Biotechnology Reports (2025) Vol. 45, pp. e00881-e00881
Open Access
Angiotensin-(1-7) protective effects in neurocognitive disorders: molecular mechanisms to therapeutic implications
Lillia Lucas, Katherine Kimbark, Victoria Vernail, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
Potentiation of NMDA Receptors by AT1 Angiotensin Receptor Activation in Layer V Pyramidal Neurons of the Rat Prefrontal Cortex
Adrienn Hanuska, Polett Ribiczey, Erzsébet Kató, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12644-12644
Open Access | Times Cited: 3
Discovery of New Nanomolar Selective IRAP Inhibitors
Ben He, Nour Bou Karroum, Ronan Gealageas, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Alamandine enhanced spatial memory in rats by reducing neuroinflammation and altering BDNF levels in the hippocampus and prefrontal cortex
Aysu Kılıç, Betül Esra Ipek, Suzin Tatonyan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The Brain AT2R—a Potential Target for Therapy in Alzheimer’s Disease and Vascular Cognitive Impairment: a Comprehensive Review of Clinical and Experimental Therapeutics
Heba A. Ahmed, Tauheed Ishrat
Molecular Neurobiology (2020) Vol. 57, Iss. 8, pp. 3458-3484
Open Access | Times Cited: 24
The Angiotensin-Converting Enzyme Inhibitor Lisinopril Mitigates Memory and Motor Deficits in a Drosophila Model of Alzheimer’s Disease
Jimiece Thomas, Haddon Smith, C.A. Smith, et al.
Pathophysiology (2021) Vol. 28, Iss. 2, pp. 307-319
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top